First-In-Human Study to Evaluate Single and Multiple Ascending Doses of JUV-161 in Healthy Adult Volunteers
Clinical trial NCT06918925 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06918925
- Sponsor
- Juvena Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-14
- Primary completion
- 2026-05-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.